The interconnected and cross-border nature of risks posed by infectious diseases

Global Health Action

Volumn 7, Issue 1, 2014, Pages

  Suk, Jonathan E ^a,b   Van Cangh, Thomas ^a   Beauté, Julien ^a   Bartels, Cornelius ^a   Tsolova, Svetla ^a   Pharris, Anastasia ^a   Ciotti, Massimo ^a   Semenza, Jan C ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Climate change; Ebola; Epidemic; Globalization; Health determinants; Infectious disease

Indexed keywords

COMMERCIAL PHENOMENA; COMMUNICABLE DISEASES; EPIDEMIC; FOOD HANDLING; HEALTH; HUMAN; INFECTION CONTROL; MIGRATION; RISK FACTOR; SOCIOECONOMICS; TRAVEL; WEATHER;

COMMERCE; COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DISEASE OUTBREAKS; EMIGRATION AND IMMIGRATION; FOOD HANDLING; GLOBAL HEALTH; HUMANS; RISK FACTORS; SOCIOECONOMIC FACTORS; TRAVEL; WEATHER;

EID: 84929508850     PISSN: None     EISSN: 16549880     Source Type: Journal    
DOI: 10.3402/gha.v7.25287     Document Type: Review

References (129)

1. Piot P. Ebola's perfect storm. Science 2014; 345: 1221.
2. Daszak P. Anatomy of a pandemic. Lancet 2012; 380: 1883-4.
3. Khan K, Arino J, Hu W, Raposo P, Sears J, Calderon F, et al. Spread of a novel influenza A (H1N1) virus via global airline transportation. N Engl J Med 2009; 361: 212-14.
4. McNeill WH. Plagues and peoples. Garden City, NY: Anchor Press; 1976.
5. World Economic Forum (2014). Global risks 2014. 9th ed. Geneva: World Economic Forum.
6. Bogich TL, Chunara R, Scales D, Chan E, Pinheiro LC, Chmura AA, et al. Preventing pandemics via international development: a systems approach. PLoS Med 2012; 9: e1001354.
7. Suk JE, Semenza JC. Future infectious disease threats to Europe. Am J Public Health 2011; 101: 2068-79.
8. Weiss RA, McMichael AJ. Social and environmental risk factors in the emergence of infectious diseases. Nat Med 2004; 10: S70-6.
9. Garrett AL, Park YS, Redlener I. Mitigating absenteesim in hospital workers during a pandemic. Disaster Med Public Health Prep 2009; 3(Suppl 2): S141-7.
10. Ansell C, Boin A, Keller A. Managing transboundary crises: identifying the building blocks of an effective response system. J Contingencies Crisis Manage 2010; 18: 195-207.
11. IPCC. Managing the risks of extreme events and disasters to advance climate change adaptation. A Special Report of Working Groups I and II of the Intergovernmental Panel on Climate Change. Cambridge, UK: Cambridge University Press; 2012.
12. Hansen J, Sato M, Ruedy R. Perception of climate change. Proc Natl Acad Sci U S A 2012; 109: E2415-23.
13. IPCC. Summary for policymakers. In: Stocker TF, Qin D, Plattner GK, Tignor M, Allen SK, Boschung J, et al., eds. Climate change 2013: the physical science basis Contribution of Working Group I to the Fifth Assessment Report of the Intergovernmental Panel on Climate Change. Cambridge: Cambridge University Press; 2013.
14. McMichael AJ. Globalization, climate change, and human health. N Engl J Med 2013; 368: 1335-43.
15. Lindgren E, Andersson Y, Suk JE, Sudre B, Semenza JC. Public health. Monitoring EU emerging infectious disease risk due to climate change. Science 2012; 336: 418-19.
16. Confalonieri U, Menne B, Akhtar R, Ebi KL, Hauengue M, Kovats RS, et al. Human Health. In: Parry ML, Canziani OF, Palutikof JP, van der Linden PJ, Hanson CE, eds. Climate change 2007: impacts, adaptation and vulnerability contribution of Working Group II to the Fourth Assessment Report of the Intergovernmental Panel on Climate Change. Cambridge: Cambridge University Press; 2007.
17. Altizer S, Ostfeld RS, Johnson PTJ, Kutz S, Harvell CD. Climate change and infectious diseases: from evidence to a predictive framework. Science 2013; 341: 514-19.
18. Semenza JC, Menne B. Climate change and infectious diseases in Europe. Lancet Infect Dis 2009; 9: 365-75.
19. Chaves LF, Koenraadt CJM. Climate change and highland malaria: fresh air for a hot debate. Q Rev Biol 2010; 85: 27-55.
20. Confalonieri UEC, Margonari C, Quintão AF. Environmental change and the dynamics of parasitic diseases in the Amazon. Acta Tropica 2013; 129: 33-41.
21. Siraj AS, Santos-Vega M, Bouma MJ, Yadeta D, Carrascal DR, Pascual M. Altitudinal changes in malaria incidence in highlands of Ethiopia and Colombia. Science 2014; 343: 1154-8.
22. Jaenson TGT, Jaenson DGE, Eisen L, Petersson E, Lindgren E. Changes in the geographical distribution and abundance of the tick Ixodes ricinus during the past 30 years in Sweden. Parasit Vectors 2012; 5: 8. English.
23. Caminade C, Kovats S, Rocklov J, Tompkins AM, Morse AP, Colon-Gonzalez FJ, et al. Impact of climate change on global malaria distribution. Proc Natl Acad Sci U S A 2014; 111: 3286-91.
24. Beguin A, Hales S, Rocklöv J, Åström C, Louis VR, Sauerborn R. The opposing effects of climate change and socio-economic development on the global distribution of malaria. Global Environ Change 2011; 21: 1209-14.
25. Naish S, Dale P, Mackenzie JS, McBride J, Mengersen K, Tong S. Climate change and dengue: a critical and systematic review of quantitative modelling approaches. BMC Infect Dis 2014; 14: 167. English.
26. Fischer D, Thomas SM, Suk JE, Sudre B, Hess A, Tjaden NB, et al. Climate change effects on chikungunya transmission in Europe: geospatial analysis of vector's climatic suitability and virus' temperature requirements. Int J Health Geogr 2013; 12.
27. Gething PW, Smith DL, Patil AP, Tatem AJ, Snow RW, Hay SI. Climate change and the global malaria recession. Nature 2010; 465: 342-5.
28. Smith KR, Woodward A, Campbell-Lendrum D, Chadee D, Honda Y, Liu Q, et al. Chapter 11. Human health: impacts, adaptation, and co-benefits. In: Field CB, Barros VR, Dokken DJ, Mach KJ, Mastrandrea MD, Bilir TE, et al., eds. Climate change 2014: impacts, adaptation, and vulnerability Part A: global and sectoral aspects contribution of Working Group II to the Fifth Assessment Report of the Intergovernmental Panel on Climate Change. Cambridge: Cambridge University Press; 2014, pp. 1-69.
29. Paz S, Semenza JC. Environmental drivers of West Nile fever epidemiology in Europe and Western Asia-a review. Int J Environ Res Public Health. 2013; 10: 3543-62. English.
30. Kovats RS, Edwards SJ, Hajat S, Armstrong BG, Ebi KL, Menne B. The effect of temperature on food poisoning: a timeseries analysis of salmonellosis in ten European countries. Epidemiol Infect 2004; 132: 443-53.
31. Semenza JC, Hoser C, Herbst S, Rechenburg A, Suk JE, Frechen T, et al. Knowledge mapping for climate change and food-and Waterborne diseases. Crit Rev Environ Sci Technol 2012; 42: 378-411. English.
32. Semenza JC, Herbst S, Rechenburg A, Suk JE, Hoser C, Schreiber C, et al. Climate change impact assessment of foodand Waterborne diseases. Crit Rev Environ Sci Technol 2012; 42: 857-90. English.
33. Karesh WB, Dobson A, Lloyd-Smith JO, Lubroth J, Dixon MA, Bennett M, et al. Ecology of zoonoses: natural and unnatural histories. Lancet 2012; 380: 1936-45.
34. Patz JA, Daszak P, Tabor GM, Aguirre AA, Pearl M, Epstein J, et al. Unhealthy landscapes: policy recommendations on land use change and infectious disease emergence. Environ Health Perspect 2004; 112: 1092-8.
35. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, et al. Global trends in emerging infectious diseases. Nature 2008; 451: 990-3.
36. Randolph SE, Rogers DJ. The arrival, establishment and spread of exotic diseases: patterns and predictions. Nat Rev Microbiol 2010; 8: 361-71.
37. Tatem AJ, Hay SI, Rogers DJ. Global traffic and disease vector dispersal. Proc Natl Acad Sci U S A 2006; 103: 6242-7.
38. Tatem AJ, Huang Z, Das A, Qi Q, Roth J, Qiu Y. Air travel and vector-borne disease movement. Parasitology 2012; 139: 1816-30.
39. Gautret P, Botelho-Nevers E, Brouqui P, Parola P. The spread of vaccine-preventable diseases by international travellers: a public-health concern. Clin Microbiol Infect 2012; 18(Suppl 5): 77-84.
40. ECDC (2014). Assessing the burden of key infectious diseases among migrant populations in the EU/EEA. Stockholm: ECDC.
41. ECDC (2013). Hepatitis B and C surveillance in Europe, 2006-2011. Stcokholm: ECDC.
42. Health WCoSDa (2008). Closing the gap in a generation: health equity through action on the social determinants of health. Geneva: WHO.
43. Semenza JC, Giesecke J. Intervening to reduce inequalities in infections in Europe. Am J Public Health 2008; 98: 787-92.
44. Suhrcke M, Stuckler D, Suk JE, Desai M, Senek M, McKee M, et al. The impact of economic crises on communicable disease transmission and control: a systematic review of the evidence. PLoS One 2011; 6: e20724.
45. OECD (2013). Crisis squeezes income and puts pressure on inequality and poverty. Paris: OECD.
46. ECDC (2013). Health inequalities, the financial crisis and infectious disease in Europe. Stockholm: ECDC.
47. Paraskevis D, Nikolopoulos G, Fotiou A, Tsiara C, Paraskeva D, Sypsa V, et al. Economic Recession and emergence of an HIV-1 outbreak among drug injectors in Athens Metropolitan Area: a longitudinal study. PLoS One 2013; 8: e78941.
48. Pharris A, Wiessing L, Sfetcu O, Hedrich D, Botescu A, Fotiou A, et al. Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. Euro Surveill 2011; 16.
49. Arinaminpathy N, Dye C. Health in financial crises: economic recession and tuberculosis in Central and Eastern Europe. J Roy Soc Interface 2010; 7: 1559-69.
50. Larson HJ, Leask J, Aggett S, Sevdalis N, Thomson A. A multidisciplinary research agenda for understanding vaccine-related decisions. Vaccines 2013; 1: 293-304.
51. Dubé E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J. Vaccine hesitancy: an overview. Hum Vaccin Immunother 2013; 9: 1763-73.
52. Brown KF, Long SJ, Ramsay M, Hudson MJ, Green J, Vincent CA, et al. UK parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis. Vaccine 2012; 30: 1855-64.
53. ECDC (2012). Review of outbreaks and barriers to MMR vaccination coverage among hard-to-reach populations in Europe. Stockholm: ECCD.
54. OECD (2013). Health at glance 2013: OECD indicators. Paris: OECD.
55. Chen LH, Wilson ME. The globalization of healthcare: implications of medical tourism for the infectious disease clinician. Clin Infect Dis 2013; 57: 1752-9.
56. Greer S, Jarman H. Managing risks in EU health services policy: spot markets, legal certainty and bureaucratic resistance. J Eur Soc Policy 2012; 22: 259-72.
57. Mackey TK, Liang BA. Restructuring brain drain: strengthening governance and financing for health worker migration. Glob Health Action 2013; 6: 1-7.
58. Huttner A, Harbarth S, Carlet J, Cosgrove S, Goossens H, Holmes A, et al. Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum. Antimicrob Resist Infect Control 2013; 2: 31.
59. WHO (2014). Antimicrobial resistance: global report on surveillance. Geneva: WHO.
60. Havelaar AH, Cawthorne A, Angulo F, Bellinger D, Corrigan T, Cravioto A, et al. WHO initiative to estimate the Global Burden of Foodborne Diseases. Lancet 2013; 381: S59.
61. McEntire J. Foodborne Disease. The global movement of food and people. Infect Dis Clin North America 2013; 27: 687-93.
62. Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, et al. Isolation and characterization of viruses related to the SARS coronavirus from animals in Southern China. Science 2003; 302: 276-8.
63. Hahn BH, Shaw GM, De Cock KM, Sharp PM. AIDS as a zoonosis: scientific and public health implications. Science 2000; 287: 607-14.
64. Rouquet P, Froment JM, Bermejo M, Kilbourn A, Karesh W, Reed P, et al. Wild animal mortality monitoring and human ebola outbreaks, Gabon and Republic of Congo, 2001-2003. Emerg Infect Dis 2005; 11: 283-90.
65. Febriani Y, Levallois P, Lebel G, Gingras S. Association between indicators of livestock farming intensity and hospitalization rate for acute gastroenteritis. Epidemiol Infect 2009; 137: 1073-85.
66. Singer RS, Cox LA Jr, Dickson JS, Hurd HS, Phillips I, Miller GY. Modeling the relationship between food animal health and human foodborne illness. Prev Vet Med 2007; 79: 186-203.
67. Gilchrist MJ, Greko C, Wallinga DB, Beran GW, Riley DG, Thorne PS. The potential role of concentrated animal feeding operations in infectious disease epidemics and antibiotic resistance. Environ Health Perspect 2007; 115: 313-16.
68. Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clin Microbiol Rev 2011; 24: 718-33.
69. World Economic Forum (2013). Global Risks 2013. 8th ed. Geneva: World Economic Forum.
70. Gubler DJ. Dengue, urbanization and globalization: the unholy trinity of the 21 st century. Trop Med Health 2011; 39(Suppl 4): 3-11.
71. Pialoux G, Gaüzère BA, Jauréguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 2007; 7: 319-27.
72. Burt FJ, Rolph MS, Rulli NE, Mahalingam S, Heise MT. Chikungunya: a re-emerging virus. Lancet 2012; 379: 662-71. English.
73. Benedict MQ, Levine RS, Hawley WA, Lounibos LP. Spread of the tiger: global risk of invasion by the mosquito Aedes albopictus. Vector-Borne Zoonotic Dis 2007; 7: 76-85.
74. Rogers DJ, Suk JE, Semenza JC. Using global maps to predict the risk of dengue in Europe. Acta Tropica 2013; 129: 1-14.
75. Reiter P, Sprenger D. The used tire trade: a mechanism for the worldwide dispersal of container breeding mosquitoes. J Am Mosquito Contr Assoc 1987; 3: 494-501.
76. Roiz D, Neteler M, Castellani C, Arnoldi D, Rizzoli A. Climatic factors driving invasion of the tiger mosquito (Aedes albopictus) into new areas of Trentino, Northern Italy. PLoS One 2011; 6: e14800.
77. ECDC (2009). Development of Aedes albopictus risk maps. Stockholm: ECDC. Report No.
78. Fischer D, Thomas SM, Niemitz F, Reineking B, Beierkuhnlein C. Projection of climatic suitability for Aedes albopictus Skuse (Culicidae) in Europe under climate change conditions. Global Planet Change 2011; 78: 54-64.
79. Tsetsarkin KA, McGee CE, Volk SM, Vanlandingham DL, Weaver SC, Higgs S. Epistatic roles of E2 glycoprotein mutations in adaption of Chikungunya virus to Aedes albopictus and Ae, Aegypti mosquitoes. PLoS One 2009; 4: e6835.
80. Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, et al. Infection with chikungunya virus in Italy: an outbreak in a temperate region. Lancet 2007; 370: 1840-6.
81. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature 2013; 496: 504-7.
82. Gjenero-Margan I, Aleraj B, Krajcar D, Lesnikar V, Klobucar A, Pem-Novosel I, et al. Autochthonous dengue fever in Croatia, August-September 2010. Euro Surveill 2011; 16.
83. La Ruche G, Souares Y, Armengaud A, Peloux-Petiot F, Delaunay P, Despres P, et al. First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill 2010; 15: 19676.
84. HajioffS, McKee M. The health of the Roma people: a review of the published literature. J Epidemiol Community Health 2000; 54: 864-9.
85. Parekh N, Rose T. Health inequalities of the Roma in Europe: a literature review. Cent Eur J Public Health 2011; 19: 139-42.
86. Lim TA, Marinova L, Kojouharova M, Tsolova S, Semenza JC. Measles outbreak in Bulgaria: poor maternal educational attainment as a risk factor for medical complications. Eur Journal of Public Health 2013; 23: 663-9.
87. Masseria C, Mladovsky P, Hernández-Quevedo C. The socioeconomic determinants of the health status of Roma in comparison with non-Roma in Bulgaria, Hungary and Romania. Eur J Public Health 2010; 20: 549-54. English.
88. NCIPD (2012). National Center of Infectious and Parasitic Diseases. Available From http://www.ncipd.org/[cited 5 January 2012].
89. International Monetary Fund. World economic outlook data 2012. Available from: http://www.imf.org/external/pubs/ft/weo/2012/01/weodata/WEOApr2012all.xls [cited 21 September 2012].
90. Kojouharova M. Current outbreak of hepatitis A in Bulgaria, 2006. Euro Surveill 2006; 11: E061005 1.
91. Kojouharova M, Zuber PL, Gyurova S, Fiore L, Buttinelli G, Kunchev A, et al. Importation and circulation of poliovirus in Bulgaria in 2001. Bull World Health Organ 2003; 81: 476-81.
92. Rechel B, Suhrcke M, Tsolova S, Suk JE, Desai M, McKee M, et al. Economic crisis and communicable disease control in Europe: a scoping study among national experts. Health Policy 2011; 103: 168-75.
93. Cox NJ, Subbarao K. Influenza. Lancet 1999; 354: 1277-82.
94. Poovorawan Y, Pyungporn S, Prachayangprecha S, Makkoch J. Global alert to avian influenza virus infection: from H5N1 to H7N9. Pathog Glob Health 2013; 107: 217-23.
95. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353: 1374-85.
96. Chen E, Chen Y, Fu L, Chen Z, Gong Z, Mao H, et al. Human infection with avian influenza A(H7N9) virus re-emerges in China in winter 2013. Euro Surveill 2013; 18.
97. Yu H, Wu JT, Cowling BJ, Liao Q, Fang VJ, Zhou S, et al. Effect of closure of live poultry markets on poultry-to-person transmission of avian influenza A H7N9 virus: an ecological study. Lancet 2014; 383: 541-8.
98. Guan Y, Smith GJ. The emergence and diversification of panzootic H5N1 influenza viruses. Virus Res 2013; 178: 35-43.
99. Si Y, de Boer WF, Gong P. Different environmental drivers of highly pathogenic avian influenza H5N1 outbreaks in poultry and wild birds. PLoS One 2013; 8: e53362.
100. Fournie G, Guitian J, Desvaux S, Cuong VC, Dung DH, Pfeiffer DU, et al. Interventions for avian influenza A (H5N1) risk management in live bird market networks. Proc Natl Acad Sci U S A 2013; 110: 9177-82.
101. Tamerius J, Nelson MI, Zhou SZ, Viboud C, Miller MA, Alonso WJ. Global influenza seasonality: reconciling patterns across temperate and tropical regions. Environ Health Perspect 2011; 119: 439-45.
102. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003; 362: 1733-45.
103. Cowling BJ, Jin L, Lau EHY, Liao Q, Wu P, Jiang H, et al. Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a populationbased study of laboratory-confirmed cases. Lancet 2013; 382: 129-37.
104. Hall C. Impact of avian influenza on U.S. poultry trade relations-2002: H5 or H7 low pathogenic avian influenza. Ann N Y Acad Sci 2004; 1026: 47-53.
105. Peasah SK, Azziz-Baumgartner E, Breese J, Meltzer MI, Widdowson MA. Influenza cost and cost-effectiveness studies globally-a review. Vaccine 2013; 31: 5339-48.
106. Smith RD, Keogh-Brown MR, Barnett T, Tait J. The economywide impact of pandemic influenza on the UK: a computable general equilibrium modelling experiment. BMJ 2009; 339: 1298.
107. Gulland A. WHO workers are shot at during vaccination campaign in Pakistan. BMJ 2012; 345: e4951.
108. Hawkes N. Doctor who helped locate bin Laden family worked for the CIA. BMJ 2012; 344: e785.
109. Lenzer J. Fake vaccine campaign in Pakistan could threaten plans to eradicate polio. BMJ 2011; 343: d4580.
110. Roberts L. Israel's silent polio epidemic breaks all the rules. Science 2013; 342: 679-80.
111. ECDC (2013). Risk of introduction and transmission of wildtype poliovirus in EU/EEA countries following events in Israel and Syria-updated risk assessment. Stockholm: European Centre for Disease Prevention and Control.
112. Murele B, Vaz R, Gasasira A, Mkanda P, Erbeto T, Okeibunor J. Vaccine perception among acceptors and non-acceptors in Sokoto State, Nigeria. Vaccine 2014; 32: 3323-7. English.
113. Murakami H, Kobayashi M, Hachiya M, Khan ZS, Hassan SQ, Sakurada S. Refusal of oral polio vaccine in northwestern Pakistan: a qualitative and quantitative study. Vaccine 2014; 32: 1382-7. English.
114. Coutts A, Fouad FM. Response to Syria's health crisis-poor and uncoordinated. Lancet 2013; 381: 2242-3.
115. Okeibunor J, Gasasira A, Mihigo R, Salla M, Poy A, Orkeh G, et al. Trend in proportions of missed children during polio supplementary immunization activities in the African Region: evidence from independent monitoring data 2010-2012. Vaccine 2014; 32: 1067-71. English.
116. McMichael AJ. Prisoners of the proximate: loosening the constraints on epidemiology in an age of change. Am J Epidemiol 1999; 149: 887.
117. Susser M, Susser E. Choosing a future for epidemiology: II. From black box to Chinese boxes and eco-epidemiology. Am J Public Health 1996; 86: 674.
118. Parkes MW, Bienen L, Breilh J, Hsu LN, McDonald M, Patz JA, et al. All hands on deck: Transdisciplinary approaches to emerging infectious disease. EcoHealth 2005; 2: 258-72.
119. Butler C. Infectious disease emergence and global change: thinking systemically in a shrinking world. Infect Dis Poverty 2012; 1: 5.
120. Rabinowitz PM, Kock R, Kachani M, Kunkel R, Thomas J, Gilbert J, et al. Toward proof of concept of a one health approach to disease prediction and control. Emerg Infect Dis 2013; 19.
121. Semenza JC, Sudre B, Oni T, Suk JE, Giesecke J. Linking environmental drivers to infectious diseases: the European environment and epidemiology network. PLoS Negl Trop Dis 2013; 7: e2323.
122. Woolhouse M. How to make predictions about future infectious disease risks. Philos Trans R Soc B Biol Sci 2011; 366: 2045-54.
123. Nelson CD, Beckjord EB, Dausey DJ, Chan E, Lotstein D, Lurie N. How can we strengthen the evidence base in public health preparedness? Disaster Med Public Health Prep 2008; 2: 247-50.
124. Sudre B, Rossi M, Van Bortel W, Danis K, Baka A, Vakalis N, et al. Mapping environmental suitability for malaria transmission, Greece. Emerg Infect Dis 2013; 19: 784-6.
125. ECDC. E3 Geoportal 2014. Available from: http://e3devint.ecdcnet.europa.eu/SitePages/Vibrio Risk Map.aspx [cited 7 August 2014].
126. Baker-Austin C, Trinanes JA, Taylor NGH, Hartnell R, Siitonen A, Martinez-Urtaza J. Emerging Vibrio risk at high latitudes in response to ocean warming. Nat Clim Change 2013; 3: 73-7.
127. Funk S, Salathé M, Jansen VAA. Modelling the influence of human behaviour on the spread of infectious diseases: a review. J Roy Soc Interface 2010; 7: 1247-56.
128. Larson HJ, Smith DMD, Paterson P, Cumming M, Eckersberger E, Freifeld CC, et al. Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines. Lancet Infect Dis 2013; 13: 606-13.
129. Salathé M, Bengtsson L, Bodnar TJ, Brewer DD, Brownstein JS, Buckee C, et al. Digital Epidemiology. PLoS Comput Biol 2012; 8: e1002616.